Vero Biotech INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$68Kgeneral payments (2019-2025)
$31Kresearch payments (2019-2025)
67clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2020 $1,824
2022 $34K
2023 $28K
2024 $4,408

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Pediatric Anesthesiology $51K
Internal Medicine $12K
Anesthesiology $1,767
Pediatric Critical Care Medicine $1,325
Pulmonary Disease $664
Neonatal-Perinatal Medicine $352

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Mark Twite Aurora, CO Pediatric Anesthesiology $50,278.35
Scott Van Poppel Phoenix, AZ Internal Medicine $11,836.88
Robert Newmyer Syracuse, NY Pediatric Critical Care Medicine $1,200.00
John Mcconnell Louisville, KY Pulmonary Disease $218.53
Gary Rodberg Hendersonville, NC Pulmonary Disease $179.45
Jeffrey Marshall Glen Burnie, MD Pulmonary Disease $158.85
Faye Evans Atlanta, GA Anesthesiology $133.22
Antoine Soliman Orange, CA Neonatal-Perinatal Medicine $131.71
Constantinos Chrysostomou Fountain Valley, CA Pediatric Cardiology $131.71
Branden Engorn San Diego, CA Pediatric Critical Care Medicine $125.00

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.